ContractTemasek Holdings (Private) LTD • July 30th, 2015 • Industrial organic chemicals • Delaware
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT’), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID SECURITIES ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION.
Virtu Financial, Inc. Lock-Up Agreement May 10, 2018Lock-Up Agreement • May 15th, 2018 • Temasek Holdings (Private) LTD • Security brokers, dealers & flotation companies
The undersigned understands that Jefferies LLC and Morgan Stanley & Co. LLC, as Representatives (the “Representatives”), propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) on behalf of the several Underwriters named in Schedule I to such agreement (collectively, the “Underwriters”), with Virtu Financial, Inc., a Delaware corporation (the “Company”), providing for a public offering of shares of Class A common stock, par value $0.00001 per share (the “Class A Common Stock”) of the Company (the “Shares”) pursuant to a Registration Statement on Form S-3 (the “Registration Statement”) to be filed with the Securities and Exchange Commission (the “SEC”). The undersigned further understands that the Company is authorized to issue, in addition to the Class A Common Stock, shares of Class B common stock, par value $0.00001 per share (the “Class B Common Stock”), shares of Class C stock, par value $0.00001 per share (the “Class C Common Stock”), and shares of Class D c
ContractLimited Guarantee • November 23rd, 2020 • Temasek Holdings (Private) LTD • Biological products, (no disgnostic substances) • New York
This LIMITED GUARANTEE, dated as of November 19, 2020 (this “Limited Guarantee”), is made by V-Sciences Investments Pte Ltd, a company incorporated under the Laws of the Republic of Singapore (the “Guarantor”), in favor of China Biologic Products Holdings, Inc., an exempted company incorporated with limited liability under the Laws of the Cayman Islands (the “Guaranteed Party”). This Limited Guarantee is being delivered to the Guaranteed Party concurrently with the execution and delivery of the Merger Agreement (as defined below). Unless otherwise defined herein, capitalized terms used herein shall have the meanings assigned to them in the Merger Agreement.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • January 24th, 2020 • Temasek Holdings (Private) LTD • Biological products, (no disgnostic substances) • New York
This SHARE PURCHASE AGREEMENT, dated as of January 23, 2020 (this “Agreement”), by and between Double Double Holdings Limited, a Cayman Islands company (the “Seller”) and V-Sciences Investments Pte Ltd, a private limited company incorporated under the laws of the Republic of Singapore (the “Purchaser”). The Seller and the Purchaser shall be referred to hereinafter collectively as the “Parties” and each a “Party.” Capitalized terms not otherwise defined shall have the meanings ascribed in Section 6.1 hereof.
FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT of UNIVAR INC. Dated as of June 23, 2015Stockholders Agreement • July 6th, 2015 • Temasek Holdings (Private) LTD • Prefabricated wood bldgs & components • Delaware
THIS FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (as amended and restated from time to time according to its terms, this “Agreement”), dated as of June 23, 2015, relating to Univar Inc., a Delaware corporation (the “Company”), is entered into by and among the Company, CD&R Univar Holdings, L.P., a Cayman Islands exempted limited partnership (“CD&R Investor”), Univar N.V., a limited liability company (naamloze vennootschap) organized under the laws of the Netherlands and with corporate seat in Rotterdam, the Netherlands (“Univar NV”), Dahlia Investments Pte. Ltd. (“Temasek Investor”), and each of the stockholders of the Company whose name appears on Annex A hereto (together with and each Person that has previously executed or subsequently executes an Accession Agreement, the “Stockholders” and each, individually, a “Stockholder”).
FIRST AMENDMENT TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 6th, 2015 • Temasek Holdings (Private) LTD • Prefabricated wood bldgs & components • New York
THIS FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (as amended and restated from time to time according to its terms, this “Agreement”), dated as of [●], 2015, relating to Univar Inc., a Delaware corporation (the “Company”), is entered into by and among the Company, CD&R Univar Holdings, L.P., a Cayman Islands exempted limited partnership (“CD&R Investor”), Univar N.V., a limited liability company (naamloze vennootschap) organized under the laws of the Netherlands and with corporate seat in Rotterdam, the Netherlands (“Univar NV”), Dahlia Investments Pte. Ltd. (“Temasek Investor”), and each of the stockholders of the Company whose name appears on Annex A hereto (together with and each Person that subsequently executes an Accession Agreement, the “Stockholders” and each, individually, a “Stockholder”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Temasek Holdings (Private) LTD • Services-business services, nec
The undersigned hereby agree that the statement on Schedule 13G, dated February 14, 2022 (the “Schedule 13G”), with respect to the voting common stock, $0.0001 par value per share, of Flywire Corporation is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an exhibit to the Schedule 13G and each such amendment.
EXCHANGE AGREEMENTExchange Agreement • July 28th, 2015 • Temasek Holdings (Private) LTD • Industrial organic chemicals • Delaware
This EXCHANGE AGREEMENT (this “Agreement”) is made and entered into as of July 26, 2015, by and between Amyris, Inc., a Delaware corporation (the “Company”), and the individuals or entities listed on Schedule I hereto (each, an “Investor,” and collectively, the “Investors”).
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • September 10th, 2021 • Temasek Holdings (Private) LTD • Services-computer processing & data preparation • Delaware
THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (as it may be amended, supplemented or restated from time to time in accordance with the terms hereof, this “Agreement”), dated as of September 1, 2021 (the “Effective Date”), is made by and among (i) E2open Parent Holdings, Inc., a Delaware corporation and successor to CC Neuberger Principal Holdings I, a Cayman Islands exempted company (including any of its successors or assigns, “PubCo”); (ii) (A) Insight Venture Partners Growth-Buyout Coinvestment Fund (Cayman), L.P., a Cayman Islands exempted limited partnership (“GBCF Cayman”), (B) Insight Venture Partners Growth-Buyout Coinvestment Fund (Delaware), L.P., a Cayman Islands exempted limited partnership (“GBCF Delaware”), (C) Insight Venture Partners (Cayman) IX, L.P., a Cayman Islands exempted limited partnership (“IVP Cayman”) and (D) Insight Venture Partners (Delaware) IX, L.P., a Delaware limited partnership (together with GBCF Cayman, GBCF Delaware, and IVP Cayman, the “IVP Bl
VOTING AGREEMENTVoting Agreement • July 30th, 2015 • Temasek Holdings (Private) LTD • Industrial organic chemicals • Delaware
This VOTING AGREEMENT (this “Agreement”) is entered into as of July 29, 2015, by and between the stockholder listed on the signature page hereto (the “Stockholder”), and Amyris, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein but not otherwise defined shall have the meaning given to them in the Exchange Agreement (as defined below).
VOTING AGREEMENT among ST ASSEMBLY TEST SERVICES LTD and the STOCKHOLDERS OF CHIPPAC, INC. identified on the signature pages hereto Dated as of February 10, 2004Voting Agreement • February 20th, 2004 • Temasek Holdings LTD • Semiconductors & related devices • Delaware
VOTING AGREEMENT, dated as of February 10, 2004 (this “Agreement”), among ST ASSEMBLY TEST SERVICES LTD, a Singapore public company limited by shares (“Parent”), and the stockholders (each a “Stockholder”) of ChipPAC, Inc., a Delaware corporation (the “Company”), identified on the signature pages hereto.
VOTING AGREEMENTVoting Agreement • May 9th, 2017 • Temasek Holdings (Private) LTD • Industrial organic chemicals • Delaware
This VOTING AGREEMENT (this “Agreement”) is entered into as of May 5, 2017, by and between the stockholder listed on the signature page hereto (the “Stockholder”), and Amyris, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein but not otherwise defined shall have the meaning given to them in the Purchase Agreements (as defined below).
AMENDED AND RESTATED LOCK-UP WAIVERS AGREEMENTLock-Up Waivers Agreement • July 31st, 2017 • Temasek Holdings (Private) LTD • Security brokers, dealers & flotation companies • Delaware
This Agreement is entered into as of April 20, 2017 (this “Agreement”), by and among Virtu Financial, Inc., a Delaware corporation (the “Company”), and each of the persons set forth on Schedule A hereto (each, a “Stockholder” and, collectively, the “Stockholders” and together with the Company, the “Parties”).
JOINT FILING AGREEMENTJoint Filing Agreement • September 30th, 2008 • Temasek Holdings (Private) LTD • Security brokers, dealers & flotation companies
We, the signatories of this Statement on Schedule 13G/A to which this Agreement is attached, hereby agree that such Statement is, and any amendments thereto filed by either of us will be, filed on behalf of each of us.
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2021 • Temasek Holdings (Private) LTD • Retail-catalog & mail-order houses
The undersigned hereby agree that the statement on Schedule 13G, dated February 16, 2021 (the “Schedule 13G”), with respect to the Class A common stock, par value $0.0001 per share, of ContextLogic Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an exhibit to the Schedule 13G and each such amendment.
AMYRIS, INC. AMENDMENT NO. 6 TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT’ Rights Agreement • July 30th, 2015 • Temasek Holdings (Private) LTD • Industrial organic chemicals • California
This Amendment No. 6 to the Amended and Restated Investors’ Rights Agreement (this “Amendment”) is made and entered into as of July 29, 2015, by and among Amyris, Inc., a Delaware corporation (the “Company”), the Investors and the Common Holders.
JOINT FILING AGREEMENTJoint Filing Agreement • October 25th, 2019 • Temasek Holdings (Private) LTD • Biological products, (no disgnostic substances)
This joint filing agreement (this “Agreement”) is made and entered into as of October 25, 2019, by and among Temasek Holdings (Private) Limited, Fullerton Management Pte Ltd, Temasek Life Sciences Private Limited, V-Sciences Investments Pte Ltd and TLS Beta Pte. Ltd.
JOINT FILING AGREEMENTJoint Filing Agreement • January 26th, 2022 • Temasek Holdings (Private) LTD • Investment advice
This joint filing agreement (this “Agreement”) is made and entered into as of January 26, 2022, by and among Temasek Holdings (Private) Limited, Fullerton Management Pte Ltd, Temasek Life Sciences Private Limited, and V-Sciences Investments Pte Ltd.
AMENDMENT NO. 1 TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2018 • Temasek Holdings (Private) LTD • Security brokers, dealers & flotation companies • Delaware
This Amendment No. 1 to Amended and Restated Registration Rights Agreement, dated as of May 10, 2018 (this “Amendment”), is entered into by and among Virtu Financial, Inc. (the “Company”) and the parties named on the signature pages hereto (collectively, the “Parties”). Capitalized terms used herein and not otherwise defined shall have their respective meanings set forth in the Registration Rights Agreement (as defined below).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Temasek Holdings (Private) LTD • Miscellaneous electrical machinery, equipment & supplies
This joint filing agreement (this “Agreement”) is made and entered into as of February 14, 2022, by and among Temasek Holdings (Private) Limited, Tembusu Capital Pte. Ltd., Thomson Capital Pte. Ltd., Anderson Investments Pte. Ltd., Temasek Capital (Private) Limited, Seletar Investments Pte. Ltd. and Aranda Investments Pte. Ltd.
JOINT FILING AGREEMENTJoint Filing Agreement • March 29th, 2018 • Temasek Holdings (Private) LTD • Telephone communications (no radiotelephone)
In accordance with Rule 13(d)-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing with each other of the attached Statement on Schedule 13D and to all amendments to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 5th, 2021 • Temasek Holdings (Private) LTD • Biological products, (no disgnostic substances)
The undersigned hereby agree that the statement on Schedule 13G, dated February 5, 2021 (the “Schedule 13G”), with respect to the common stock, par value $0.01 per share, of Beam Therapeutics Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an exhibit to the Schedule 13G and each such amendment.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2012 • Temasek Holdings (Private) LTD • Commercial banks, nec
The undersigned, Temasek Holdings (Private) Limited, Fullerton Management Pte Ltd, Fullerton Financial Holdings Pte. Ltd. and Allamanda Investments Pte Ltd, hereby agree and acknowledge that the information required by this Schedule 13G/A, to which this Agreement is attached as an exhibit, is filed on behalf of each of them. The undersigned further agree that any further amendments or supplements hereto shall also be filed on behalf of each of them.
JOINT FILING AGREEMENTJoint Filing Agreement • September 10th, 2021 • Temasek Holdings (Private) LTD • Services-computer processing & data preparation
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the common stock of E2Open Parent Holdings, Inc., and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings. This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • October 17th, 2019 • Temasek Holdings (Private) LTD • Pharmaceutical preparations
This joint filing agreement (this “Agreement”) is made and entered into as of October 17, 2019, by and among Temasek Holdings (Private) Limited, Fullerton Management Pte Ltd, Temasek Life Sciences Private Limited, V-Sciences Investments Pte Ltd and TLS Beta Pte. Ltd.
JOINT FILING AGREEMENTJoint Filing Agreement • June 1st, 2021 • Temasek Holdings (Private) LTD • Telephone communications (no radiotelephone)
The undersigned hereby agree that the statement on Schedule 13G, dated June 1, 2021 (the “Schedule 13G”), with respect to the common stock, par value $1.00 per share, of Lumen Technologies, Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an exhibit to the Schedule 13G and each such amendment.
JOINT FILING AGREEMENTJoint Filing Agreement • November 13th, 2020 • Temasek Holdings (Private) LTD • Biological products, (no disgnostic substances)
This joint filing agreement (this “Agreement”) is made and entered into as of November 13, 2020, by and among Temasek Holdings (Private) Limited, Fullerton Management Pte. Ltd., Temasek Life Sciences Private Limited, Elbrus Investments Pte. Ltd., and V-Sciences Investments Pte Ltd.
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2018 • Temasek Holdings (Private) LTD • Retail-catalog & mail-order houses
We, the signatories of this Statement on Schedule 13G to which this Agreement is attached, hereby agree that such Statement is, and any amendments thereto filed by any of us will be, filed on behalf of each of us.
AMENDMENT NO. 1 TO AMENDED AND RESTATED LOCK-UP WAIVERS AGREEMENTWaivers Agreement • May 15th, 2018 • Temasek Holdings (Private) LTD • Security brokers, dealers & flotation companies • Delaware
This Amendment No. 1 to Amended and Restated Lock-up Waivers Agreement, dated as of May 10, 2018 (this “Amendment”), is entered into by and among Virtu Financial, Inc. (the “Company”) and the parties named on the signature pages hereto (collectively, the “Parties”). Capitalized terms used herein and not otherwise defined shall have their respective meanings set forth in the Waiver Agreement (as defined below).
JOINT FILING AGREEMENTJoint Filing Agreement • April 11th, 2018 • Temasek Holdings (Private) LTD • Pharmaceutical preparations
This joint filing agreement (this “Agreement”) is made and entered into as of April 11, 2018, by and among Temasek Holdings (Private) Limited, Fullerton Management Pte Ltd, Temasek Life Sciences Private Limited, V-Sciences Investments Pte Ltd and TLS Beta Pte. Ltd.
JOINT FILING AGREEMENTJoint Filing Agreement • November 13th, 2018 • Temasek Holdings (Private) LTD • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13G with respect to the securities beneficially owned by each of them of Orchard Therapeutics plc. This Joint Filing Agreement shall be included as an Exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • May 15th, 2020 • Temasek Holdings (Private) LTD • Security brokers, dealers & flotation companies
The undersigned hereby agree that the statement on Schedule 13G, dated May 15, 2020 (the “Schedule 13G”), with respect to the Class A common stock, par value $0.00001 per share, of Virtu Financial, Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an exhibit to the Schedule 13G and each such amendment.
JOINT FILING AGREEMENTJoint Filing Agreement • February 11th, 2008 • Temasek Holdings (Private) LTD • Semiconductors & related devices
We, the signatories of this Statement on Schedule 13G to which this Agreement is attached, hereby agree that such Statement is, and any amendments thereto filed by any of us will be, filed on behalf of each of us.
JOINT FILING AGREEMENTJoint Filing Agreement • April 22nd, 2020 • Temasek Holdings (Private) LTD • Services-prepackaged software
This joint filing agreement (this “Agreement”) is made and entered into as of April 22, 2020, by and among Temasek Holdings (Private) Limited, Fullerton Management Pte. Ltd., Hotham Investments Pte. Ltd., and Ossa Investments Pte. Ltd.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 25th, 2013 • Temasek Holdings (Private) LTD • Services-computer programming, data processing, etc. • New York
WHEREAS, the Investor and the Company have entered into a Purchase Agreement on September 30, 2013 (the “Purchase Agreement”), pursuant to which the Investor purchased the Sale Shares (as defined in the Purchase Agreement) subject to the terms and conditions as set forth in the Purchase Agreement.
